Global cancer statistics, Global cancer statistics, pp.69-90, 2011. ,
DOI : 10.3322/caac.20107
Genetic analysis of breast cancer in the cancer and steroid hormone study, Am J Hum Genet, vol.48, pp.232-242, 1991. ,
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994. ,
DOI : 10.1126/science.7545954
Identification of the breast cancer susceptibility gene BRCA2, Nature, vol.72, issue.6559, pp.789-792, 1995. ,
DOI : 10.1038/378789a0
Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer, New England Journal of Medicine, vol.358, issue.26, pp.2796-2803, 2008. ,
DOI : 10.1056/NEJMsa0708739
Ten Genes for Inherited Breast Cancer, Cancer Cell, vol.11, issue.2, pp.103-105, 2007. ,
DOI : 10.1016/j.ccr.2007.01.010
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles, Nature Genetics, vol.42, issue.11, pp.1239-1241, 2006. ,
DOI : 10.1038/ng1902
MR: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Breast Cancer Susceptibility Collaboration (UK) Nat Genet, vol.39, pp.165-167, 2007. ,
Inherited Susceptibility to Common Cancers, New England Journal of Medicine, vol.359, issue.20, pp.2143-2153, 2008. ,
DOI : 10.1056/NEJMra0802968
Biallelic Inactivation of BRCA2 in Fanconi Anemia, Science, vol.297, issue.5581, pp.606-609, 2002. ,
DOI : 10.1126/science.1073834
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J, Nature Genetics, vol.37, issue.9, pp.934-935, 2005. ,
DOI : 10.1126/science.1088753
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer, Nature Genetics, vol.12, issue.2, pp.162-164, 2007. ,
DOI : 10.1038/ng1947
RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis, Seminars in Cell & Developmental Biology, vol.22, issue.8, pp.898-905, 2011. ,
DOI : 10.1016/j.semcdb.2011.07.019
Mutation of the RAD51C gene in a Fanconi anemia???like disorder, Nature Genetics, vol.176, issue.5, pp.406-409, 2010. ,
DOI : 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N
Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation: Figure 1, Journal of Medical Genetics, vol.49, issue.3, pp.184-186, 2012. ,
DOI : 10.1136/jmedgenet-2011-100585
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nature Genetics, vol.668, issue.5, pp.410-414, 2010. ,
DOI : 10.1016/S0301-472X(02)00782-8
Germline mutations in RAD51D confer susceptibility to ovarian cancer, Nature Genetics, vol.52, issue.9, pp.879-882, 2011. ,
DOI : 10.1002/gepi.1014
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer, The American Journal of Human Genetics, vol.90, issue.4, pp.734-739, 2012. ,
DOI : 10.1016/j.ajhg.2012.02.027
Rare variants in XRCC2 as breast cancer susceptibility alleles: Table??1, Journal of Medical Genetics, vol.49, issue.10, pp.618-620, 2012. ,
DOI : 10.1136/jmedgenet-2012-101191
Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families, Breast Cancer Research and Treatment, vol.21, issue.2, pp.255-263, 2011. ,
DOI : 10.1007/s10549-011-1539-6
EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients, Human Mutation, vol.42, issue.Suppl 2, pp.325-334, 2011. ,
DOI : 10.1002/humu.21414
URL : https://hal.archives-ouvertes.fr/hal-00613913
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral, Journal of Medical Genetics, vol.43, issue.4, pp.295-305, 2006. ,
DOI : 10.1136/jmg.2005.033878
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nature Protocols, vol.4, issue.8, pp.1073-1081, 2009. ,
DOI : 10.1101/gr.772403
A method and server for predicting damaging missense mutations, Nature Methods, vol.7, issue.4, pp.248-249, 2010. ,
DOI : 10.1038/nmeth0410-248
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants, Human Mutation, vol.39, issue.8, pp.1228-1238, 2012. ,
DOI : 10.1002/humu.22101
A specific translocation, t(12;14)(q14???15; q23???24), characterizes a subgroup of uterine leiomyomas, Cancer Genetics and Cytogenetics, vol.32, issue.1, pp.13-17, 1988. ,
DOI : 10.1016/0165-4608(88)90305-6
Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas, Cancer Res, vol.59, pp.19-23, 1999. ,
Haploinsufficiency of RAD51B Causes Centrosome Fragmentation and Aneuploidy in Human Cells, Cancer Research, vol.66, issue.12, pp.6018-6024, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-2803
Amultistagegenome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24, Nat Genet, vol.1, issue.41, pp.579-584, 2009. ,
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk, Nature Genetics, vol.44, issue.11, pp.1182-1184, 2012. ,
DOI : 10.1371/journal.pgen.1000054
) Gene Variants and the Risk of Isolated Cleft Lip or Palate, New England Journal of Medicine, vol.351, issue.8, pp.769-780, 2004. ,
DOI : 10.1056/NEJMoa032909
Rare Variants Create Synthetic Genome-Wide Associations, PLoS Biology, vol.81, issue.1, 2010. ,
DOI : 10.1371/journal.pbio.1000294.t001
Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case???control studies, Molecular Biology Reports, vol.315, issue.2, pp.5125-5134, 2012. ,
DOI : 10.1007/s11033-011-1308-y
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients, Human Mutation, vol.124, issue.1, pp.95-99, 2012. ,
DOI : 10.1002/humu.21625
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families, Breast Cancer Research and Treatment, vol.8, issue.3, pp.939-946, 2011. ,
DOI : 10.1007/s10549-011-1543-x
Germline RAD51C mutations confer susceptibility to ovarian cancer, Eccles, pp.475-476, 2012. ,
DOI : 10.1038/ng.2224
Germline mutation in the RAD51B gene confers predisposition to breast cancer, BMC Cancer, vol.44, issue.1, p.484, 2013. ,
DOI : 10.1038/ng.2224
URL : https://hal.archives-ouvertes.fr/inserm-00878230